Brian L Hood, PhD
Director of Proteomics
Gynecologic Cancer Center of Excellence
3289 Woodburn Rd
Suite 375
Annandale,
VA
USA
22003
Papers:
11 - Focused Plenary
Molecular profiling of tumors from stage I versus stage III/IV cancer patients: a prediction signature for metastasis in Gynecologic Oncology Group 8024
43 - Featured Poster
Identification of candidate circulating cisplatin resistance biomarkers from epithelial ovarian carcinoma cell secretomes
49 - Featured Poster
Pathogenesis of ARID1A-driven gynecologic cancer
306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells
334 - Poster Session A
Proteomic profiling of stage I endometrial cancers: a signature of early-stage recurrence in GOG 8016
337 - Poster Session A
Proteomics of endometrial carcinogenesis: identification of candidates underlying disease pathogenesis
525 - Poster Session B
Correlation of survival-stratified proteomic and curated gene data reveal a three protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer